You can buy or sell CBIO and other stocks, options, and ETFs commission-free!
Catalyst Biosciences, Inc. Common Stock, also called Catalyst Biosciences, is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA. The listed name for CBIO is Catalyst Biosciences, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Feb 18, Pre-Market